Table 6.
Univariate and multivariate analyses of prognostic factors associated with 5-year overall survival
|
Variables
|
N
|
Univariate
|
Multivariate
|
||
|
5-yr OS rate (%)
|
P
value
|
HR (95%CI)
|
P
value
|
||
| Total | 195 | ||||
| Sex | |||||
| Male | 128 | 87.9 | 0.3274 | ||
| Female | 67 | 85.3 | |||
| Age | |||||
| < 65 | 77 | 89.7 | 0.4113 | ||
| 65 | 118 | 85.2 | |||
| Location | |||||
| U | 41 | 80.9 | 0.2629 | ||
| M, L | 154 | 88.6 | |||
| Tumor length (mm) | |||||
| < 30 | 63 | 97.8 | 0.0020a | 3.010 (0.347-26.12) | 0.3176 |
| 30 | 132 | 80.1 | |||
| Histological type | |||||
| tub1, tub2, pap | 96 | 88.3 | 0.4544 | ||
| por, sig, muc | 99 | 85.6 | |||
| Lymphatic invasion | |||||
| Negative | 110 | 96.1 | 0.0002a | 1.872 (0.549-6.384) | 0.3166 |
| Positive | 85 | 75.7 | |||
| Venous invasion | |||||
| Negative | 131 | 90.6 | 0.0126a | 1.085 (0.476-2.472) | 0.8469 |
| Positive | 64 | 79.3 | |||
| pT | |||||
| pT1-2 | 137 | 95.9 | < 0.0001a | 5.240 (1.807-15.20) | 0.0023c |
| pT3-4 | 58 | 65.5 | |||
| pN | |||||
| pN0 | 139 | 94.1 | < 0.0001a | 2.148 (0.695-6.643) | 0.1844 |
| pN1-3 | 56 | 67.6 | |||
| IHC score | |||||
| < 1.3 | 137 | 89.6 | 0.0104a | 2.318 (1.016-5.288) | 0.0457c |
| 1.3 | 58 | 73.9 | |||
P < 0.05: Log-rank test.
P < 0.05: Cox hazard regression analysis.
CI: Confidence interval; HR: Hazard ratio; IHC: Immunohistochemical; L: Lower; M: Middle; muc: Mucinous adenocarcinoma; OS: Overall survival; pap: Papillary adenocarcinoma; pN: Pathological N stage; por: Poorly differentiated adenocarcinoma; pT: Pathological T stage; sig: Signet-ring cell carcinoma; tub: Tubular adenocarcinoma; U: Upper.